Navigation Links
US Oncology Reports First Quarter 2008 Results
Date:5/7/2008

e required to estimate a value that would be allocated to goodwill in a hypothetical purchase transaction using an estimate of the segment's fair value as the purchase price. This estimation process also requires the identification and valuation of intangible assets that have either increased in value or have been created through Company initiatives and investments. Any value assigned to identified intangible assets reduces the amount attributable to goodwill.

In addition to the goodwill impairment charge, we recognized restructuring and other charges which relate primarily to employee severance costs amounting to $1.3 million in the first quarter of 2008. These amounts are excluded from Adjusted EBITDA.

During the first quarter of 2008 and fourth quarter of 2007 we also recognized an unrealized loss of $16.0 million and $11.6 million, respectively, related to the Company's interest rate swap, due to decreasing LIBOR rates. Because the interest rate swap is not accounted for as a cash flow hedge, changes in the fair value of the instrument are reported currently in earnings. Although cash flow hedge accounting is no longer applied to the interest rate swap, the Company believes the swap, economically, remains a hedge against the variability of interest payments on a portion of its outstanding floating rate debt. The non-cash charge on the interest rate swap is excluded from Adjusted EBITDA.

Cash Flow

During the first quarter of 2008, operating cash flow was $50.9 million, compared to $23.7 million in the first quarter of 2007. The increase is primarily due to improved receivable collections and the election to pay interest due March 15, 2008 on the Holdings notes, in kind. Operating cash flow decreased $23.3 million from $74.2 million in the fourth quarter of 2007 due to payments made to physicians, earned in 2007 under programs that encourage their efficient use of capital and services in our pharmaceutical services segment, as well as s
'/>"/>

SOURCE US Oncology Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine news :

1. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
2. ESMO, Oxford Journals and the Japanese Society of Medical Oncology announce collaboration
3. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference
4. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
5. US Oncology to Report 2007 Third Quarter Earnings Results
6. VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting
7. Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines
8. Varian Medical Systems Ranks First in Overall Service Performance in 2007 Survey of U.S. Radiation Oncology Professionals
9. Accuray Announces Four New Products at Nations Leading Radiation Oncology Meeting
10. Debiopharm and NanoCarrier Sign License and Supply Agreement for Dach-Platin Polymeric Micelle in Oncology
11. National Autism Association and Deirdre Imus Environmental Center for Pediatric Oncology Announce National Greening Your School Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013 Phoseon Technology will present ... the 20th Annual IMI European Ink Jet Conference ... leader, Phoseon continues to invest in product development to ... of UV LED curing in printing applications. Phoseon ... the market offering both air cooled and water cooled ...
(Date:5/21/2013)... Modern couples have countless strains ... Counseling’s Sexuality and Relationship Workshops, couples are learning ... healthier habits for their relationship. There are both ... and individuals at Texas Counseling. Their goal is ... skills to develop long term solutions. , ...
(Date:5/21/2013)... of Defense Serum Repository (DoDSR), University of Cincinnati (UC) ... bowel disease (IBD), which could help with earlier diagnosis ... symptoms. , This finding, the first of its kind ... presented via podium presentation by staff from Walter Reed ... being held May 18-21 in Orlando, Fla. , ...
(Date:5/21/2013)... The Las Vegas personal injury law firm Benson, ... Gates, a senior at Coronado High School, is the winner ... . As the winner of the essay contest, Crawford received ... Dec. 1, 2012 and ran through April 30th, 2013. Participating ... minimum essay on “The Role of the civil tort system.” ...
(Date:5/21/2013)... A new study appearing in the current issue ... harvested from fat (adipose) are more potent than those ... body’s immune system. , The finding could have ... tissue-derived stem cells (AT-SCs) are far more plentiful in ... can be collected from waste material from liposuction procedures. ...
Breaking Medicine News(10 mins):Health News:Workshops Offered To Identify Underlying Challenges That Put Strain On Relationships 2Health News:Biomarkers discovered for inflammatory bowel disease 2Health News:Benson, Bertoldo, Baker & Carter is Pleased to Announce the Winner of its First Annual College Scholarship Essay Contest 2Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 2Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 3
... PARK, Md., June 5 Dynasplint Systems, Inc. --, ... 34th annual,Severna Park Independence Day Parade and Festival. Held ... at St. Martin,s -in-the-field and,Our Shepherd Lutheran churches on ... and family activities at Cypress Creek Park., This ...
... Predicts Growing Opposition on Capitol Hill Once Negative Impact ... June 5 In thanking U.S.,Senators Kent Conrad (D-ND), ... (D-ND) and Shelley Moore Capito (R-WV) for leading a,new ... plan to,cut by regulatory means $770 million in seniors, ...
... Ind., June 5 Hill-Rom (NYSE: HRC ... Award for the,TotalCare(R) Bariatric Plus therapy system. The ... This is the second year in a row,that ... award., The TotalCare Bariatric Plus therapy system ...
... also provides business update, including fourth-quarter fiscal 2008 ... ... Iowa, June 5 Meredith Corporation,(NYSE: MDP ), one of ... Communications, a leading healthcare,marketing communications firm. Additionally, the company provided a,business ...
... to reject unfair offer, study shows , , THURSDAY, June 5 ... serotonin govern the way people react to unfair offers when ... , Serotonin, which carries messages between neurons, is involved in ... anger in women was affected by variations in a gene ...
... apparently solved a long-standing frustration in creating certain synthetic molecules ... with fewer side effects. , Like human hands, many molecules ... left. But usually only one of the two versions has ... sometimes even harmful. For example, side effects from the morning ...
Cached Medicine News:Health News:Front Line Caregiver Coalition Thanks Sens. Conrad, Coleman and Reps. Pomeroy, Capito and Berkley for Leading Bipartisan Hill Effort to Stop Bush Administration's Damaging Medicare Cuts 2Health News:Hill-Rom Innovative TotalCare(R) Bariatric Plus Therapy System Receives Gold Medical Device Excellence Award 2Health News:Hill-Rom Innovative TotalCare(R) Bariatric Plus Therapy System Receives Gold Medical Device Excellence Award 3Health News:Meredith Expands Integrated Marketing Capabilities by Acquiring Top Healthcare Marketing Communications Firm 2Health News:Meredith Expands Integrated Marketing Capabilities by Acquiring Top Healthcare Marketing Communications Firm 3Health News:Meredith Expands Integrated Marketing Capabilities by Acquiring Top Healthcare Marketing Communications Firm 4Health News:Meredith Expands Integrated Marketing Capabilities by Acquiring Top Healthcare Marketing Communications Firm 5Health News:Serotonin Levels Determine Sense of Fairness 2Health News:Duke chemist has new way to tell right from left 2
(Date:5/21/2013)... -- Tom Daulton, CEO of Mammotome, a division of Devicor Medical ... Cincinnati chapter of the Association for ... top executive who is also a breast cancer survivor, led ... March of 2010. Daulton will be presented with the award ... Bank, on May 22. The ACG Deal Maker ...
(Date:5/21/2013)... May 21, 2013 Kepner-Tregoe (KT), the ... that 13-year veteran Chris Geraghty ... experience includes more than 20 years serving the ... manufacturing organizations. He succeeds Ray Baxter ... Kepner-Tregoe,s Chairman of the Board and CEO. ...
(Date:5/21/2013)... 2013  Armada Health Care (Armada) is pleased ... corporate website ( www.armadahealthcare.com ).  This new website ... first-to-market services and its position as the leading ... pharmacy industry. The updated website visibly ... model in delivering an extensive portfolio of services ...
Breaking Medicine Technology:Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year 2Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year 3Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 2Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 3Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace 2
... Toll-Like Receptor 3 (TLR3) Agonist, SAN DIEGO, ... announced that the company has developed a,proprietary vaccine ... for use in both therapeutic and prophylactic vaccines., ... a Toll-like Receptor 3 (TLR3) agonist that when ...
... N.C., June 18 Pilot Therapeutics,Holdings, Inc. ... as Gene,Smart(TM) Health., (Logo: http://www.newscom.com/cgi-bin/prnh/20080618/CLW006LOGO ... gene-based nutrition, Gene Smart(TM) Health uniquely,combines breakthrough ... health, food, nutrition, and wellness markets to ...
Cached Medicine Technology:Nventa Develops Proprietary Vaccine Adjuvant 2Nventa Develops Proprietary Vaccine Adjuvant 3Nventa Develops Proprietary Vaccine Adjuvant 4Pilot Therapeutics Announces Relaunch as Gene Smart(TM) Health 2
...
Conforms to the convexity of the lens providing easier access to anterior capsule. Reduces pontential of corneal touch. 35G x 5/8in (.50 x 16mm)...
Conforms to the convexity of the lens providing easier access to anterior capsule. Reduces pontential of corneal touch. 25G x 5/8in (.50 x 16mm)...
... Unique product designed for LASIK surgery ... Designed to irrigate the corneal interface ... easy insertion under the flap and ... ports provide multi-directional irrigation.27G x 7/8in ...
Medicine Products: